A detailed history of Brandywine Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Brandywine Trust CO holds 116,669 shares of ABT stock, worth $12.1 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares
116,669
Previous 116,669 -0.0%
Holding current value
$12.1 Million
Previous $12.8 Million 3.26%
% of portfolio
2.25%
Previous 2.58%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $116,232 - $136,812
-1,200 Reduced 1.02%
116,669 $11.8 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $46,009 - $53,975
-484 Reduced 0.41%
117,869 $12.9 Million
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $1.48 Million - $1.81 Million
-13,000 Reduced 9.9%
118,353 $14 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $157,236 - $192,527
-1,361 Reduced 1.03%
131,353 $18.5 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $621,797 - $687,889
-5,330 Reduced 3.86%
132,714 $15.7 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $580,020 - $632,056
-5,524 Reduced 3.85%
138,044 $15.1 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $1.05 Million - $1.28 Million
-11,481 Reduced 7.4%
143,568 $15.6 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $171,864 - $186,354
-2,100 Reduced 1.34%
155,049 $13 Million
Q4 2018

Feb 12, 2019

SELL
$65.56 - $74.27 $267,550 - $303,095
-4,081 Reduced 2.53%
157,149 $11.4 Million
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $106,504 - $117,549
-1,850 Reduced 1.13%
161,230 $9.83 Million
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $104,099 - $117,697
1,850 Added 1.15%
163,080 $9.77 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $7.75 Million - $8.65 Million
161,230
161,230 $8.6 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Brandywine Trust CO Portfolio

Follow Brandywine Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Trust CO with notifications on news.